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The global spread of antibiotic resistance 
genes (ARGs) and their acquisition by clini-
cally relevant microorganisms is associated 
with the increased hospitalization and mor-
tality rates of patients that are infected with 
such microorganisms, which constitutes a 
serious problem for the health and welfare 
of both humans and animals1. The effect of 
clinically relevant ARGs and antibiotic 
resistant bacteria (ARB) that are released 
from anthropogenic sources, together with 
the excessive use of antibiotics in both 
human and veterinary settings, is currently 
considered to be a serious environmental 
problem1–5. However, current risk assess-
ment models are inadequate to evaluate the 
effect of antibiotics and ARGs on resistance 
emergence and selection, especially in  
non-clinical environments.
In contrast to many chemical contami-
nants — the concentration of which typically 
diminishes owing to degradation, dilution 
or sorption — bacterial contaminants (and 
their ARGs, which are present both within 
bacterial genomes and in free DNA) are 
capable of persisting and even spreading in 
the environment. The ARGs carried by these 
bacterial contaminants can multiply in their 
hosts, be passed on to other bacterial popu-
lations and be subject to further evolution. 
As such, ARB that occur in the environment  
represent potentially serious risks for 
human health.
The increased dissemination of ARB in 
the environment is probably caused by three 
principle mechanisms, which can occur in 
combination: horizontal gene transfer of 
ARGs; genetic mutation and recombination 
(which can be favoured by the existence of 
hypermutator bacterial strains); and the 
proliferation of ARB owing to selective 
pressures that are imposed by antimicrobial 
compounds or other contaminants, such as 
biocides or heavy metals6–10. As bacterial  
communities are shaped by a complex 
array of evolutionary, ecological and envi-
ronmental factors, it is difficult to predict 
the fate of ARGs and ARB that are released 
into the environment, or to obtain a clear 
understanding of the evolution and ecology 
of antibiotic resistance in this setting. For 
example, although the excessive use of anti-
biotics may select for resistant populations 
in the environment, other biotic and abiotic 
factors (such as physicochemical conditions, 
environmental contaminants, induction of 
stress responses, bacterial adaptation and 
phenotypic heterogeneity) have the potential 
to enhance the effect of selective pressures 
and promote bacterial evolution towards 
antibiotic resistance. Conversely, there is still 
a poor understanding of the environmental 
factors that may alleviate the spread of  
antibiotic resistance.
Antibiotic resistance hotspots are found 
not only in medical settings but also in envi-
ronmental compartments that are subjected 
to anthropogenic pressure, such as munici-
pal wastewater systems, pharmaceutical 
manufacturing effluents, aquaculture facili-
ties and animal husbandry facilities. These 
sites are characterized by extremely high 
bacterial loads coupled with subtherapeutic 
concentrations of antibiotics, and they con-
tribute to the discharge of ARB and ARGs 
into the environment. At present, it is not 
clear to what extent environmental ARB and 
ARGs promote the acquisition and spread 
of antibiotic resistance among clinically 
relevant bacteria, or whether ARGs that are 
acquired by both clinically relevant bacteria 
and strictly environmental bacteria origi-
nate from the same reservoirs11–13. However, 
for these issues to be properly addressed, 
global efforts are required to characterize 
and quantify antibiotic resistance in the 
environment. In particular, it is necessary 
to create an adequate support for advanced 
biological risk assessment evaluations, which 
are needed to determine how contaminated 
environments affect the proliferation of 
antibiotic resistance. In parallel, the imple-
mentation of technological solutions that 
can reduce the contamination of natural eco-
systems by clinically relevant and potentially 
evolving ARB and ARGs is also a priority.
These topics were the focus of the 
European COST (Cooperation in Science 
and Technology) Action DARE (Detecting 
Evolutionary Hotspots of Antibiotic 
Resistance in Europe, TD 0803), which was 
launched in 2009 and completed in 2013. 
This interdisciplinary project involved 20 
European countries and 123 scientists with  
a wide range of backgrounds (for example,  
engineers, microbiologists, chemists, 
veterinarians and physicians, working at 
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universities, research institutes, national 
health agencies and national veterinary 
agencies). In this Opinion article, we pre-
sent our consensus on the main knowledge 
gaps, future research needs, policy options 
and management options that should be 
prioritized when tackling antibiotic resis-
tance in the environment (FIG. 1). A holistic 
view of antibiotic resistance evolution is 
proposed, which considers the emergence 
and dynamics of ARB and ARGs in relevant 
environmental compartments and includes 
the identification of both conditions that 
can enhance its spread and relevant points 
of control.
Standardization of resistance testing
Over the past two decades, important 
advances have been made regarding the 
international implementation of standard-
ized methods to monitor antibiotic resistance 
in clinical isolates. These advances were 
essential in enabling the comparison of 
resistance prevalence in different geographi-
cal regions to assess possible relationships 
between antibiotic resistance and antibiotic 
consumption, and to acquire a temporal 
perspective on resistance dynamics1. Despite 
the ever-increasing evidence that the evolu-
tion and spread of antibiotic resistance in the 
environment contributes to the occurrence 
of anti biotic resistance in clinical or urban 
settings2–9, standardized methods that are 
directly applicable to environmental samples 
(which enable reliable comparisons with 
clinical data) have never been developed. 
Therefore, microbiologists and environmental 
scientists worldwide have adapted clinical 
criteria — usually based on pre-established 
breakpoints, which offer an objective classi-
fication of an organism as either resistant 
or susceptible to a given antibiotic10 — to 
define and examine antibiotic resistance in 
water, sludge, sediment, plant, manure and 
soil samples14–16. However, the conditions 
and criteria for bacterial isolation, and the 
number of isolates that are necessary to obtain 
a representative set of species (or even the 
prevailing species), are completely different in 
environmental samples compared to those in 
clinical samples. Furthermore, most environ-
mental bacteria are not recovered in culture-
dependent surveys. Last, the definitions of 
resistance used for clinical isolates, which are 
mainly based on the likelihood of therapeutic 
failure of human or animal bacterial infections, 
may not apply to environmental bacteria15,16. 
These shortcomings have motivated the 
development of methods that can give a more 
comprehensive overview of the prevalence of 
resistance in environmental samples.
One approach that has been used to 
evaluate the status of antibiotic resistance 
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Figure 1 | Minimizing the spread of antibiotic resistance in the environ-
ment. The figure summarizes the current goals (purple boxes) in trying to 
minimize the emergence and spread of antibiotic resistance genes (ARGs) and 
antibiotic resistant bacteria (ARB) in the environment and their transmission 
into the clinic. The current needs and limitations that must be resolved to 
achieve these goals are also shown (yellow boxes). To evaluate the spread of 
antibiotic resistance in the environment, and the risk of transmission to 
humans, it is necessary to define what constitutes resistance in environmental 
bacterial strains and to standardize testing in environmental samples. This 
improvement in the definition and testing of resistance should contribute to 
the establishment of more comprehensive databases that combine data from 
both environmental and clinical settings. These databases would contribute 
to the evaluation of the relationship between the antibiotic resistomes in both 
settings and facilitate the mining of ARGs in metadata. These strategies would 
improve the assessment of the risk of dissemination of ARB and ARGs in the 
environment and their transmission to humans, and they would potentiate 
the development of control strategies (management and policy) aimed at 
preventing the dissemination of antibiotic resistance.
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in the environment involves the calculation 
of resistance percentage, which is based on 
the ratio between the number of bacteria 
that are able to grow on culture media that 
are supplemented with antibiotics at doses 
close to the minimal inhibitory concentra-
tion (MIC) and the number of bacteria that 
grow on antibiotic-free media16. Culture-
independent approaches, which are mainly 
based on information about ARGs that 
was previously acquired from the study of 
clinical isolates, have also been successfully 
developed17–21. In particular, quantitative 
PCR (qPCR) can give an approximation of 
the prevalence of known ARGs in environ-
mental samples, which can be a good estima-
tion of the level of contamination by ARGs, 
although careful standardization of gene 
copy numbers is needed. However, as dif-
ferent methodologies are regularly used, the 
results obtained by these approaches cannot 
be compared with those commonly used 
in surveillance reports on human medicine 
and veterinary medicine1,22. Therefore, har-
monized guidelines are needed regarding the 
number of isolates and diversity of species or 
strains to be tested; the cultivation conditions 
or the DNA extraction methods; and the tar-
geted resistance phenotypes and genotypes 
or primer sets. Such guidelines would enable 
direct comparisons between different envi-
ronmental compartments, thus establishing 
bridges with clinical data.
Standardization of resistance testing 
should further focus on bacterial indicators 
that are already in use and also on a subset 
of resistance determinants, preferably with 
both analysed concurrently. Primary bacte-
rial indicators should be members of the 
class Gammaproteobacteria or the phylum 
Firmicutes, as these are the most frequent 
carriers of acquired ARGs (BOX 1). In partic-
ular, we propose Escherichia coli and faecal  
enterococci — which are currently used to 
monitor microbiological water quality and 
are well characterized in terms of acquired 
antibiotic resistance — as indicator organ-
isms16. In addition, Pseudomonas aeruginosa, 
which is also used as an indicator of water 
quality, and Aeromonas spp., which are typi-
cal water inhabitants, should be used for the 
examination of environmental samples in 
which faecal contamination is not expected. 
Klebsiella spp., in particular Klebsiella 
pneumoniae, are also possible indicators 
to consider, as members of this group are 
present in both the environment and the 
animal gut and have frequently been found 
to be pioneers in the emergence of antibiotic 
resistance23. Although other indicator bacte-
ria would be eligible, the bacteria mentioned 
above have the advantage of being ubiqui-
tous as well as being important carriers of 
antibiotic resistance and being responsible 
for the transfer of ARGs between different 
environmental compartments13,23–26.
For the selection of resistance determi-
nants, criteria such as the clinical relevance, 
the prevalence in the environment, the 
association with mobile genetic elements 
(MGEs) and/or the potential to be acquired 
by any mode of horizontal gene transfer 
(such as conjugation, transformation or 
transduction) are important. Possible candi-
date genes, frequently occurring in environ-
mental settings that are subjected to human 
activities9,16,27,28, are shown in BOX 1.
These recommendations should not be 
regarded as attempts to narrow the focus 
of researchers; however, there is an urgent 
need for standardization of a number of 
core parameters to improve the comparability 
between studies worldwide. This is a pre-
requisite for obtaining a global perspective 
of the environmental antibiotic resistome 
irrespective of the geographical region,  
the time frame or the environmental  
compartment being analysed.
The importance of global databases
The current state of knowledge is insufficient 
to assess the distribution and abundance 
of ARB and ARGs in the environment at 
national, regional or global levels, which is a 
major limitation in determining the current 
risk of transmission of antibiotic resistance 
from the environment to human-associated 
bacteria. There are three main reasons for 
this limitation: the existing data are not 
comparable, as there are no guidelines for 
data collection; there is no formal system of 
data collation and curation for publication; 
and surveillance in environmental compart-
ments or ecosystems (such as soil and water) 
has not been encouraged. Therefore, most 
of the available data come from sporadic 
research studies rather than long-term  
monitoring efforts.
Current limitations. Phenotypic resistance 
is often interpreted based on clinical stand-
ards and recommended breakpoints, for 
example, from the European Committee 
on Antimicrobial Susceptibility Testing 
(EUCAST) or the Clinical and Laboratory 
Standards Institute (CLSI). However, the use 
of clinical breakpoints to assess the antibiotic 
susceptibility of environmental bacteria is 
inadequate, as clinical breakpoints are based 
on parameters that are only relevant for 
therapeutic success. A more reliable alterna-
tive for the interpretation of the antibiotic 
resistance of environmental bacteria may be 
the epidemiological cut-off (ECOFF) value 
developed by EUCAST, which, in a given 
Box 1 | Bacterial groups and genetic determinants
The following bacterial groups and genetic determinants have been suggested as possible 
indicators to assess the antibiotic resistance status in environmental settings.
Bacterial groups
• Escherichia coli
• Klebsiella pneumoniae
• Aeromonas spp.
• Pseudomonas aeruginosa
• Enterococcus faecalis
• Enterococcus faecium
Genetic determinants (and the proteins they encode)
• intl1 (integrase gene of class 1 integrons, a genetic platform for ARG capture)
• sul1 and sul2 (sulfonamide-resistant dihydropteroate synthase)
• bla
CTX‑M
 and bla
TEM
 (β-lactamases, frequently identified in Enterobacteriaceae)
• bla
NDM-1
 (New Delhi metallo‑β-lactamase)
• bla
VIM
 (carbapenemase, frequent in clinical Pseudomonas aeruginosa in certain areas)
• bla
KPC
 (Klebsiella pneumoniae carbapenemase)
• qnrS (quinolone pentapeptide repeat family)
• aac‑(6ʹ)-Ib‑cr (aminoglycoside acetyltransferase)
• vanA (vancomycin resistance operon gene)
• mecA (penicillin binding protein)
• ermB and ermF (rRNA adenine N-6-methyltransferase, associated with macrolide resistance)
• tetM (ribosomal protection protein, associated with tetracycline resistance)
• aph (aminoglycoside phosphotransferase)
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taxonomic group, separates the popula-
tions with acquired resistance mechanisms 
(non-wild-type) from the wild-type popula-
tions that have no resistance. In contrast to 
clinical breakpoints, the ECOFF values are 
epidemiologically based, do not relate to 
the therapeutic efficiency and do not differ 
among different committees (for example, 
EUCAST and CLSI)10. However, current 
ECOFF estimations use databases in which, 
for a given species, the number of isolates 
with a clinical origin is several orders of 
magnitude higher than that of isolates with 
an environmental origin. In addition, most 
ECOFF studies comprise microorganisms of 
relevance to human health (pathogens and 
commensals), whereas information regard-
ing non-pathogenic environmental species, 
which can be important carriers of ARGs, is 
scarce. Hence, it is questionable whether  
the current ECOFF values correctly reflect the 
distribution of resistant and wild-type bac-
teria in the environment. To improve the 
reliability of these data, and therefore their 
usefulness in the classification of bacteria of 
different origins, it is essential to supplement 
ECOFF databases with additional data from 
environmental species and isolates.
There are several public databases and 
global surveillance projects, such as the 
Antimicrobial Resistance Global Report 
on Surveillance from the World Health 
Organization (WHO)1; the European 
Centre for Disease Prevention and Control 
(ECDC)-based European Antimicrobial 
Resistance Interactive Database (EARS-Net), 
EUCAST, and the European Antimicrobial 
Susceptibility Surveillance in Animals 
(EASSA)29 in Europe; the Surveillance 
Network Database (TSN) in the USA and 
Australia; and the Study for Monitoring 
Antimicrobial Resistance Trends (SMART) 
task force30 in the Asia–Pacific region. In 
addition, there are two centralized databases 
on ARGs: the Comprehensive Antibiotic 
Resistance Database (CARD)31 and the 
Antibiotic Resistance Genes Database 
(ARDB)32. However, the number of ARGs 
described in human and animal opportu-
nistic pathogens in these databases is much 
higher than the number of ARGs described 
in environmental bacteria. Additionally, 
public databases that incorporate data from 
environmental bacteria or metagenomes 
contain genes that have been putatively 
annotated as ARGs based on the similarity 
of their nucleotide or amino acid sequences 
to those of previously described ARGs. 
However, a functional demonstration of 
the role of many sequences described as 
‘resistance genes’ in specialized databases 
is lacking, which creates a background of 
potentially misleading information for 
researchers and clinicians. The lack of a 
proper definition of antibiotic resistance 
for environmental strains of bacteria, the 
numerous databases with scant information 
on antibiotic resistance in the environment 
and the lack of functional demonstrations 
for ARGs in environmental metagenomes 
are considerable limitations for the charac-
terization of the environmental resistome 
and the assessment of its clinical relevance8.
Perspectives. The consolidation of specialized 
databases will certainly contribute to a stan-
dardized definition of ARGs and elucidate 
which genes contribute to the future acquisi-
tion of resistance by human pathogens. In 
parallel, the continuous improvement of 
techniques for the cultivation of bacteria 
using multiple culture media and conditions 
(known as culturomics) is of vital impor-
tance for the identification of ARGs and 
for understanding the cellular mechanisms 
linking ARGs and resistance phenotypes in 
different bacteria33. One of the greatest chal-
lenges in creating a consolidated database lies 
in establishing a standardized methodology 
and transforming it into a routine activity of 
environmental-quality monitoring. However, 
this is necessary if we are to acquire a coherent 
picture of environmental resistance.
Conceptually, two types of data may be 
integrated in public databases: data from 
routine monitoring (that is, from surveil-
lance databases), which will give insights 
into the distribution, prevalence, temporal 
trends and geographical trends; and data 
gathered by research studies (that is, from 
emergence and evolution databases), which 
are seeking to understand the acquisition 
and molecular evolution processes. As one of 
the most important issues concerning envi-
ronmental antibiotic resistance is its possible 
implications in the health of humans and 
animals, databases focusing on environmen-
tal bacteria should also be linked to existing 
databases on ARB and ARGs in clinical, 
veterinary and food-associated products. 
The core entries of these integrative data-
bases should comprise the ARB and ARGs 
described in BOX 1 and adopt the format of 
existing databases (for example, EARS-Net 
and REFS 31,32).
The information provided by surveillance 
databases would be substantially improved 
by the inclusion of other, systematically cho-
sen, meta-parameters. Examples include the 
occurrence of heavy metals, antibiotic resi-
due concentrations and, whenever possible, 
the composition of the microbial community, 
which would be relevant for medium- to 
long-term evaluations of resistance evolu-
tion34–36. This information could be linked to 
routine monitoring assays of environmental 
samples, particularly wastewater and sur-
face water samples37,38. Whenever possible, 
links to existing databases on MGEs (for 
example, A Classification of Mobile Genetic 
Elements (ACLAME), Insertion Sequence 
finder (ISfinder) or INTEGRALL) and 
eco-toxicological information on mole cules 
with antibacterial effects (for example, from 
the European Chemicals Agency (ECHA)) 
should be implemented to provide a compre-
hensive overview of the risk factors associ-
ated with specific antibiotic resistance (for 
example, selection, mutation and  
horizontal gene transfer).
In addition to the creation of integrative 
databases, additional data on ARGs in the 
environment are also necessary. Research on 
uncharacterized ARGs and associated MGEs, 
which are not included in the routine moni-
toring of environmental samples, is essential 
to have a thorough understanding of the 
environmental resistome. Whole-genome and 
transcriptome analyses  — including those 
that apply next-generation sequencing (NGS) 
technology — and functional metagenomic 
studies present new possibilities for decipher-
ing resistance in environmental compart-
ments. Studies on the expression and function 
of resistance genes will be fundamental in 
understanding the interplay between the 
environmental conditions and the genomic 
context, and in understanding how this rela-
tionship will influence the selection of specific 
ARGs39,40. These insights will offer the pos-
sibility of assessing the effect of external con-
ditions, such as the presence of subinhibitory 
concentrations of antibiotics, on the presence, 
expression and functionality of new and clin-
ically-associated ARGs in the environment. 
Last, these strategies may unveil unforeseen 
hotspots of antibiotic resistance. Continuous 
improvements on annotation procedures, 
such as those recently reported31,41–45, will not 
only contribute to the annotation of ARGs in 
metadata, but will also provide valuable infor-
mation about the enzymes that are respon-
sible for each resistance mechanism, mainly 
concerning new genes. The association of 
these data to both generic (for example, the 
European Molecular Biology Laboratory 
(EMBL) or GenBank) and metagenomic 
databases (for example, Metagenomic Rapid 
Annotations using Subsystems Technology 
(MG-RAST)) would further provide access 
to related sequence data and metadata  
from gene fragments to metagenomes,  
transcriptomes and proteomes.
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However, the most important associa-
tions to achieve would be those between data 
from environmental and clinical settings, 
as well as the systematic combination of 
information obtained through research and 
routine monitoring practices. This bridging 
of information will be a step forwards in  
elucidating the role of environmental  
ARGs in the emergence and evolution of 
clinically-relevant antibiotic resistance.
Risk assessment
Integrated risk assessment of the evolution  
and emergence of antibiotic resistance in 
the environment addresses two main issues: 
first, the potential of subinhibitory con-
centrations of antibiotics to promote the 
development of ARB in complex bacterial 
communities; and second, the capacity of 
resistance determinants to transfer from 
anthropogenic sources (such as treated 
wastewater, manure or others) to human 
commensal or pathogenic bacteria.
Potential of subinhibitory antibiotic 
concentrations. The Guideline on the envi-
ronmental risk assessment of medicinal 
products for human use, produced by the 
European Medicines Agency46, does not 
recognize that the emergence and prolifera-
tion of antibiotic resistance may be the most 
important risk associated with environmental 
contamination by antibiotics. Indeed, the 
endpoints for no-effect concentrations 
(NOECs; which correspond to the highest 
concentration at which a substance has no 
significant effect on the organisms exposed 
to it) are different from traditional environ-
mental risk assessment, as the effects of 
antibiotics in promoting antibiotic resist-
ance can go far beyond the toxicological 
implications. For example, even at levels 
that are considered safe according to the 
currently accepted Environmental Quality 
Standards47, antibiotics can still select for 
ARB48–50. Furthermore, these subinhibitory 
concentrations of antibiotics and antibiotic 
combinations may even induce the propa-
gation of unforeseen multidrug-resistant 
opportunistic pathogens51–54. Moreover, the 
effects of antibiotics may be potentiated or 
extended by cofactors (general stress situ-
ations and micro-contaminants, such as 
heavy metals and biocides), which possibly 
enhance the spread and evolution of anti-
biotic resistance34,54–59. Therefore, combined 
molecular- and culture-based methods are 
necessary to determine the concentrations 
at which resistance acquisition and selec-
tion is likely to occur in environmental 
compartments.
An addendum emphasizing the need 
to assess the risks posed by antimicro-
bial agents of inducing ARB selection or 
ARG emergence should be included in the 
Guideline on the environmental risk assess-
ment of medicinal products for human use. 
Although challenging, given the scarcity 
of knowledge regarding the mechanisms 
involved at the genetic, cellular and popu-
lation levels, this addendum is urgently 
needed. Within this addendum the gold 
standard of a reliable risk assessment should 
determine the range of concentrations at 
which, under defined conditions, an anti biotic 
can promote selection and the acquisition of 
resistance.
Transmission of resistance determinants 
from anthropogenic sources. Another 
important aspect of antibiotic-resistance 
risk assessment refers to the spread and 
transmission of resistance determinants 
from hotspots to downstream environ-
ments. Mathematical models capable of 
predicting the influence of potential selec-
tive pressures, or the occurrence and the 
evolutionary success of genetic recombina-
tion events, have proven to be promising 
tools in predicting the spread of antibiotic-
resistance determinants54,60,61. As they are 
specifically developed for environmental 
niches and environment–human interfaces, 
these mathematical models should rely on 
parameters such as population size; bacte-
rial population growth rate and survival; 
occurrence and frequency of horizontal 
gene transfer and its implications on the 
population fitness; and the influence of 
other biotic and abiotic factors54,60–62. Such 
models would allow predictions to be made 
regarding the dynamics of ARB hosting 
ARGs and the possible localization of ARGs 
on MGEs, thus supporting the assessment 
of their fate from anthropogenic sources to 
downstream environments. A quantitative 
risk-assessment framework should be devel-
oped by coupling data and analyses, such 
as those outlined above, with a stochastic 
assessment of exposure to clinically relevant 
bacteria in the environment. Such a model 
should then be used to predict the environ-
mental conditions that are associated with 
the evolution of antibiotic resistance and 
infer the probability of antibiotic resistance 
determinants spreading. However, owing 
to the scarcity of data on the occurrence of 
antibiotic resistance and horizontal gene 
transfer in the environment, it is currently 
difficult to develop validated models that 
can be applied in the framework of  
environmental risk-assessment guidelines.
Management and policy options
Management and policy options aimed at 
preventing and controlling antibiotic resist-
ance in the environment comprise several 
different aspects, including the choice of 
ARB and ARGs to be listed as contaminants 
of emerging concern; the determination of 
differentiated maximum admissible levels  
of an antibiotic, ARB or ARG; and the 
identification of critical points of control at 
which prevention and remediation measures 
should be implemented.
ARB and ARGs as contaminants of emerging 
concern. The European Water Framework 
Directive establishes the requirements for 
determining the biological and chemical  
quality standards of water bodies in Europe63. 
Annex I of this directive sets obligations 
for environmental quality standards (EQS) 
for priority substances and certain other 
pollu tants, and it even identifies priority 
hazardous substances. The inclusion of 
ARB and ARGs as priority contaminants 
would be justified based on the results of 
numerous scientific studies, which show 
that the occurrence of antibiotic resistance 
increases in bodies of water (such as inland 
surface waters, transitional waters, coastal 
waters and groundwater) when they are 
subjected to anthropogenic impacts, such 
as wastewater effluents, animal manure, 
agricultural runoff and wildlife living in 
urban areas21,34,64–67. We suggest the inclu-
sion of a supplement to the European Water 
Framework Directive for ARB hosting 
clinically relevant ARGs. In this context, 
it is important to establish differentiated 
guidance levels for the abundance of these 
biological contaminants in the environment. 
The application of these guidance levels may 
be especially important for the regulation of 
specific practices, such as reuse of wastewa-
ter or soil fertilization with manure.
The inclusion of ARB and ARGs in the 
list of contaminants of emerging concern 
would require clear definitions on the nec-
essary monitoring methods. Although the 
environmental survival of ARGs primarily  
depends on the host and the type of MGEs, 
the estimation of the levels of ARGs seems 
a reliable and feasible method to monitor 
antibiotic resistance. However, a crucial 
issue that needs additional investigation is 
the selection of target ARGs to be moni-
tored as indicators of resistance and the 
determination of safe concentrations of 
these genes in water. Ideally, such indicator 
genes should be abundant in anthropogenic 
sources and rare in native aquatic and ter-
restrial ecosystems to facilitate spatial and 
P E R S P E C T I V E S
314 | APRIL 2015 | VOLUME 13  www.nature.com/reviews/micro
© 2015 Macmillan Publishers Limited. All rights reserved
temporal source tracking in the environ-
ment. ARGs that are associated with MGEs 
or that present the highest environmental 
fitness (that is, long lasting survival and 
the capacity to proliferate) are good candi-
dates — for example, sul1 (which encodes 
for sulfonamide-resistant dihydropteroate 
synthase); blaTEM, blaCTX-M, blaVIM and blaNDM-1 
(which encode β-lactamases); tetM (which 
encodes for tetracycline resistance); and 
vanA (which encodes for vancomycin resist-
ance) (BOX 1). However, determination of the 
maximum acceptable levels of these genes in 
the environment seems, at the current state 
of knowledge, a challenging objective. The 
establishment of a comprehensive database 
and the use of modelling approaches would 
be valuable contributions to estimate such 
limits. Despite these challenges, this know-
ledge is an essential prerequisite, not only 
for establishing a strategy of direct action 
against antibiotic resistance in the environ-
ment, but also for the application of drugs 
and interventions directed at preventing the 
emergence and evolution of ARB and ARGs 
(eco–evo drugs)68.
Critical control points. Environmental 
hotspots, where ARB are abundant or the 
transfer of ARGs is promoted, are critical 
points for resistance control. Good examples 
of such critical points are characterized by 
a high prevalence of resistance or by the 
occurrence of resistance determinants of 
emerging concern. These locations comprise 
habitats that are influenced by human activi-
ties, such as wastewater (that is, hospital, 
urban and specific industrial wastewater) 
and waste, and wastewater from animal 
husbandry and intensive food-production 
facilities16,69,70. Moreover, sites subjected to 
the frequent discharge of antibiotic residues 
have been shown to be potential hotspots 
for the selection, proliferation and spread of 
new resistance determinants to human com-
mensal and pathogenic bacteria, and these 
sites should likewise be considered as critical 
control points71,72.
Although some of the antimicrobials 
administered to animals are used exclusively 
in veterinary applications, most belong to 
the same structural families that are used 
in human medicine. As they share the same 
basic chemical molecular structures and 
mechanisms of action, these antibiotics are 
assumed to put selective pressures on human 
commensal and pathogenic bacteria. Large 
quantities of antibiotics that are adminis-
tered to animals in intensive production sites 
are discharged, often un-metabolized, with 
manure and slurry when applied as fertilizer 
(often in a raw and unstabilized state) and 
thus contaminate soils as well as surface 
water and groundwater. At present, it is diffi-
cult to ascertain whether antibiotics reaching 
the environment at low concentrations exert 
a substantial selective pressure on ARGs or 
ARB50,51. However, there is increasing evi-
dence showing that repeated exposure of the 
environment to anthropogenically gener-
ated ARGs (for example, soil manure) cor-
relate with the emergence and proliferation 
of ARGs in indigenous microbiota66,67,73,74. 
However, the impact of animal production 
on the propagation of antibiotic resistance 
is demonstrated by some zoonotic species 
of the genera Salmonella, Campylobacter, 
Listeria, Staphylococcus, Enterococcus and 
Escherichia, which are known to exhibit high 
levels of acquired antibiotic resistance29,75–78. 
Although some animal production facili-
ties implement systems that decontaminate 
liquid and solid wastes, such treatments are 
not intended to remove ARB and might even 
promote resistance79,80. The same might be 
true for biogas reactors, which use manure 
as a substrate, because the residues of these 
reactors are used as fertilizers on agricul-
tural fields81. The confinement and treat-
ment of effluents and (processed) manure 
from intensive animal production is thus a 
priority.
Urban, hospital and pharmaceutical 
industry wastewater is among the main 
sources of antibiotic and ARB contamina-
tion in soil and water ecosystems16,21,82. In the 
environment, these contaminants can reach 
water resources for drinking water produc-
tion, enter the food chain or reach clini-
cally relevant niches9,16,17,76,82. These effects 
can be potentially even more pronounced 
when irrigation with wastewater effluents 
(wastewater reuse schemes) is applied. Water 
reuse is already a common practice in many 
regions of the world owing to increased 
water scarcity, mainly in arid and semi-arid 
regions20. Most of the wastewater treatment 
plants worldwide, in particular those using 
mechanical and biological treatments, are 
primarily designed to remove organic com-
pounds, nutrients (for example, nitrogen 
and phosphorous) and suspended solids. 
However, the currently available wastewater 
treatment processes have limited capability 
to efficiently remove organic micropollutants, 
including antibiotics and other antimicro-
bial agents82. Similarly, certain ARB and 
ARGs can survive the wastewater treatment 
processes with a maintenance (or even an 
increase) of resistance prevalence compared 
to the pretreatment levels16,17,36,64. These fea-
tures require the immediate attention of the 
scientific community and the development 
and implementation of technological solu-
tions capable of mitigating ARB and ARGs in 
wastewater to safe levels. Although the defini-
tion of a ‘safe level’ may be difficult to achieve, 
it is at least necessary to find an agreement on 
the threshold values below which the prob-
ability of significant proliferation of an ARG 
is severely impaired.
Technologies for the removal of micro-
pollutants, including antibiotics, and 
microorganisms from wastewater are 
becoming increasingly available (for exam-
ple, membrane filtration, activated carbon, 
photo-driven technologies and ozonation)82. 
However, additional research is needed 
to determine the effectiveness of these 
processes for the elimination of ARB and 
ARGs and to characterize the associated 
microbiological risks16,82. Recommendations 
of effective and economically sustainable 
interventions at critical points within the 
wastewater stream are urgently needed.
Concluding remarks
Given the public health threat posed by 
antibiotic resistance, the development and 
implementation of national and interna-
tional guidelines for the biological risk 
assessment of the emergence and propaga-
tion of ARB in the environment is a strategic 
priority. The generation of reliable compari-
sons and evaluation of temporal trends in 
antibiotic resistance in the environment are 
currently seriously limited owing to the dis-
parity of surveillance strategies. To address 
this issue, the interdisciplinary scientific 
community involved in the DARE Action 
has proposed specific priority measures.
It is necessary to improve the com-
parability between studies worldwide to 
provide the basis for a global perspective 
on the antibiotic resistome irrespective of 
geographical, temporal or environmental 
constraints. A formal system for the col-
lation and curation of data for publication 
must be implemented, and surveillance of 
environmental samples must be encouraged, 
to comprehensively assess antibiotic resist-
ance in environmental bacteria. Databases 
with multiple levels of information and 
metadata, supporting the understanding of 
antibiotic resistance dynamics on a global 
scale, must be established. An integrated 
risk-assessment platform must include the 
potential of subinhibitory concentrations of 
antibiotics to promote the development of 
ARB in complex environmental communi-
ties, and mathematical models are required 
to devise reliable risk-assessment guidelines 
on the spread of antibiotic resistance from 
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the environment to human commensal or 
pathogenic bacteria. A selection of sentinel 
ARB and ARGs should be included in the 
list of contaminants of emerging concern 
and maximum admissible levels of these 
contaminants should be defined, as well as 
the critical points of control at which pre-
vention and remediation measures can be 
implemented. Other pressing management 
options include the reduction of antibiotic 
usage; the confinement and treatment of 
problematic reservoirs, such as effluents and 
manure from intensive animal production or 
hospital effluents; and the improvement of 
current wastewater treatment technologies.
Finally, it is important to acquire a more 
comprehensive understanding of the mole-
cular, evolutionary and ecological mecha-
nisms associated with the acquisition and 
spread of antibiotic resistance. In parallel, 
the implementation of effective management 
options, mainly seeking to impose barriers 
against the dissemination of resistance from 
well-established resistance reservoirs, is 
urgently needed to combat the evolution and 
spread of antibiotic resistance, while protect-
ing human health and the environment.
Better control of the emergence and 
dissemination of ARB and ARGs does not 
replace the need to seek new therapeutic 
drugs. On the contrary, by minimising the 
evolution of ARB and ARGs, it also prepares 
the ground for new drugs to be effective for 
a longer period of time.
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